Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001058742 | SCV001223333 | uncertain significance | Amelocerebrohypohidrotic syndrome | 2022-06-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. ClinVar contains an entry for this variant (Variation ID: 853841). This variant has not been reported in the literature in individuals affected with ROGDI-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.001%). This sequence change affects codon 177 of the ROGDI mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the ROGDI protein. This variant also falls at the last nucleotide of exon 7, which is part of the consensus splice site for this exon. |
Prevention |
RCV004758141 | SCV005354064 | likely benign | ROGDI-related disorder | 2024-08-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |